TCL Archive In Brief: Senate Health Subcommittee Lineup Completed; GAO Calls For More Ionizing Radiation Studies January 23, 1981
TCL Archive Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue). May 9, 2003
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
